pentobarbital will lower the level or influence of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not recommended; sturdy cytochrome P450 enzyme inducers decrease systemic exposure to roflumilast and may decrease the therapeutic efficiencyCaution ought to be exercised any time a barbiturate i… Read More